Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes Signs Distribution, Archiving Agreement with Lawrence Livermore Lab

This article has been corrected. The previous version incorrectly stated that Lawrence Livermore National Laboratory had gained rights to archive and distribute the resources of the I.M.A.G.E. Consortium.
 
NEW YORK (GenomeWeb News) – Berlin-based ImaGenes has inked an agreement with the University of California’s Lawrence Livermore National Laboratory, under which ImaGenes is archiving and distributing all the resources of the I.M.A.G.E. (integrated molecular analysis of gene expression) Consortium.
 
The consortium is a publicly distributed resource of characterized cDNA clones, including the Mammalian Gene Collection.
 
ImaGenes said it has taken over the largest part of the RZPD German Resource Center for Genome Research’s clone collection, which includes the I.M.A.G.E. resource, and has moved the archive to the Biomedical Research Campus Berlin-Buch.
 
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.